# Safety and Efficacy of Microbial Ecosystem Therapeutic-2 (MET-2) in Patients With Ulcerative Colitis (UC)

> **NCT03832400** · PHASE1 · COMPLETED · sponsor: **NuBiyota** · enrollment: 11 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **BIOLOGICAL:** MET-2
- **DRUG:** Placebo oral capsule

## Key facts

- **NCT ID:** NCT03832400
- **Lead sponsor:** NuBiyota
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-04
- **Primary completion:** 2020-03-01
- **Final completion:** 2020-03-01
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2021-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03832400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03832400, "Safety and Efficacy of Microbial Ecosystem Therapeutic-2 (MET-2) in Patients With Ulcerative Colitis (UC)". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT03832400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*